The Washington Post, January 18th, 2005
LAST MAY, WHEN the Food and Drug Administration decided not to allow pharmacies to sell the emergency contraceptive Plan B over the counter, we wrote that the FDA was within its rights to be cautious. The agency had overridden the advice of a panel of its own experts, who pointed out that the drug is considered safe and that if taken quickly (within 72 hours of intercourse) Plan B effectively prevents unwanted pregnancies -- and therefore unwanted abortions -- both of which are good arguments for over-the-counter sales. But FDA officials were bothered by the absence of data describing the drug...
HighBeam Research, Free Preview: 'Plan B'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
